Zhao, Na <br/><br/>
Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer.  [electronic resource] 

 -  The Journal of clinical investigation  04 2018 
 - 1283-1299 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1558-8238 
<br/><br/><label>Standard No.: </label>10.1172/JCI95873  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Breast Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>Docetaxel--pharmacology<br/>Drug Delivery Systems<br/>Endoribonucleases--genetics<br/>Female<br/>Humans<br/>Mice<br/>Protein Serine-Threonine Kinases--genetics<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Response Elements<br/>Saccharomyces cerevisiae<br/>Signal Transduction--drug effects<br/>Unfolded Protein Response--drug effects<br/>X-Box Binding Protein 1--genetics<br/>Xenograft Model Antitumor Assays